SMTL ID : 4d4l.1

human PFKFB3 in complex with a pyrrolopyrimidone compound

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 3.16 Å

Oligo State

homo-dimer

Ligands

2 x PHS: PHOSPHONIC ACID(Non-covalent)

PHS.1: 6 residues within 4Å: Chain A: R.253, H.254, N.260, H.388, Q.389 Ligands: F6P.3 6 PLIP interactions: 6 interactions with chain A Hydrogen bonds: A:N.260, A:E.323, A:Q.389 Salt bridges: A:R.253, A:H.254, A:H.388 PHS.5: 6 residues within 4Å: Chain B: R.253, H.254, N.260, H.388, Q.389 Ligands: F6P.7 5 PLIP interactions: 5 interactions with chain B Hydrogen bonds: B:N.260, B:Q.389 Salt bridges: B:R.253, B:H.254, B:H.388

2 x PO4: PHOSPHATE ION(Non-functional Binders)

PO4.2: 9 residues within 4Å: Chain A: L.43, P.44, A.45, R.46, G.47, K.48, T.49, N.164, K.169 11 PLIP interactions: 11 interactions with chain A Hydrogen bonds: A:A.45, A:R.46, A:G.47, A:K.48, A:T.49, A:T.49, A:N.164 Water bridges: A:K.169, A:Y.425 Salt bridges: A:K.48, A:K.169 PO4.6: 9 residues within 4Å: Chain B: L.43, P.44, A.45, R.46, G.47, K.48, T.49, N.164, K.169 10 PLIP interactions: 10 interactions with chain B Hydrogen bonds: B:A.45, B:R.46, B:G.47, B:K.48, B:T.49, B:N.164 Water bridges: B:Y.425, B:Y.425 Salt bridges: B:K.48, B:K.169

2 x F6P: 6-O-phosphono-beta-D-fructofuranose(Non-covalent)

F6P.3: 13 residues within 4Å: Chain A: R.253, N.260, I.265, G.266, E.323, Y.334, R.348, K.352, Y.363, Q.389, R.393, T.441 Ligands: PHS.1 10 PLIP interactions: 10 interactions with chain A Hydrogen bonds: A:R.253, A:N.260, A:G.266, A:E.323, A:Y.334, A:Q.389, A:T.441 Salt bridges: A:R.348, A:K.352, A:R.393 F6P.7: 13 residues within 4Å: Chain B: R.253, N.260, I.265, G.266, E.323, Y.334, R.348, K.352, Y.363, Q.389, R.393, T.441 Ligands: PHS.5 9 PLIP interactions: 9 interactions with chain B Hydrogen bonds: B:R.253, B:N.260, B:G.266, B:Y.334, B:Y.363, B:Q.389 Salt bridges: B:R.348, B:K.352, B:R.393

2 x BKS: 5-(4-chlorophenyl)-7-phenyl-3,7-dihydro-4H-pyrrolo[2,3-d]pyrimidin-4-one(Non-covalent)

BKS.4: 13 residues within 4Å: Chain A: A.45, R.46, G.47, Y.50, I.51, S.153, V.160, N.164, E.167, V.215, V.218, L.239, V.244 11 PLIP interactions: 11 interactions with chain A Hydrophobic interactions: A:Y.50, A:Y.50, A:Y.50, A:I.51, A:V.215, A:V.218, A:V.244 Hydrogen bonds: A:S.153, A:N.164, A:V.218 Halogen bonds: A:L.239 BKS.8: 13 residues within 4Å: Chain B: A.45, R.46, G.47, Y.50, I.51, S.153, V.160, N.164, E.167, V.215, V.218, L.239, V.244 11 PLIP interactions: 11 interactions with chain B Hydrophobic interactions: B:Y.50, B:Y.50, B:Y.50, B:I.51, B:V.215, B:V.218, B:V.244 Hydrogen bonds: B:S.153, B:N.164, B:V.218 Halogen bonds: B:L.239

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Stgallay, S.A. et al., Identifying a Novel Series of Pfkfb3 Inhibitors as a Metabolic Approach to Treating Cancer from Hts, Biophysical and Biochemical Methods. To be Published

Release Date

2016-01-20

Peptides

6-PHOSPHOFRUCTO-2-KINASE/FRUCTOSE-2,6-BISPHOSPHATASE 3: AB

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

B
A

6-PHOSPHOFRUCTO-2-KINASE/FRUCTOSE-2,6-BISPHOSPHATASE 3

Related Entries With Identical Sequence